Pseudouridine Market Size, Share, Growth, and Industry Growth by Type (Powder and Solutions), By Application (Vaccines and Scientific Research), Regional Forecast To 2031

Updated On: 08 April 2024

Pseudouridine Market REPORT OVERVIEW

• 
• Request a Free sample to learn more about this report

The global pseudouridine market size was USD 126.1 million in 2022 and market is projected to touch USD 2588.62 million by 2031, exhibiting a CAGR of 39.9% during the forecast period.

The global COVID-19 pandemic has been unprecedented and staggering, with pseudouridine experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden spike in CAGR is attributable to demand returning to pre-pandemic levels once the pandemic is over.

Pseudouridine is an isomer of uridine that is used as a tumor marker which is used to guide, diagnose and monitor. It was originally present in the human body as a component such as transfer RNA. It is used for efficacy assessments of malignancies such as lung, breast, and liver cancer. It is an isomer of the nucleoside uridine where the uracil is attached through carbon-carbon. It is found in the RNA modification in cellular RNA and is abundant in nature as it is found in all 3 phylogenetic domains of life. Normal mRNA present in the vivo has uridine as one of the four nucleic acid compounds in the sequence.    

 The growing demand for pseudouridine is due to increasing cases of cancer amongst the population. Advancements and increasing research activities are expected to drive the market growth. Increasing cases of various other diseases such as MLASA due to mutations is expected to facilitate the demand for the product. Increasing R&D activities regarding the product to develop vaccines is projected to support the market during the forecast period.  

COVID-19 Impact: Use of the Product in Developing Vaccines to Support Market Growth

The effects of the COVID-19 pandemic are already being felt on a global level, the global pseudouridine market was significantly influenced. The outbreak of COVID-19 had a negative impact on several markets. Various countries went into lockdown. With sudden pandemic, all kinds of businesses observed disruptions. With many restrictions in the pandemic, different types of markets were negatively impacted. The demand for pseudouridine during the pandemic was present due to its application and contribution to developing vaccines. The vaccine developed using the product was shown to have prevented COVID-19 including illness. Novel vaccines for COVID-19 were developed based on mRNA technology. Increasing R&D activities during the pandemic helped in maintaining the demand for the product.  

LATEST TRENDS

"Advancements in mRNA Vaccines to Improve Market Progress"

The global pseudouridine market growth is anticipated to boost owing to development of prophylactic and therapeutic vaccines based on RNA-based technologies. Trials have shown that mRNA vaccines are expected to provide lasting response in humans. Advancements in RNA biology have helped in employment of increased potency of mRNA vaccines. They are expected to prevent infectious diseases and cancer prophylaxis and therapy. Such vaccines have become a powerful way to battle infectious diseases and they have the potential to be quickly manufactured. Such increasing applications of the product in the medical industry is anticipated to drive the market growth.     

Pseudouridine Market SEGMENTATION

• 
• Request a Free sample to learn more about this report

• By Type

Based on type; the market is divided into powder and solutions.

Powder is the leading part of the type segment.

• By Application

Based on application; the market is divided into vaccines and scientific research.

Vaccines are the leading part of the application segment.

DRIVING FACTORS

"Emerging Use of Product to Treat Cancer to Strengthen Market Growth"

The global pseudouridine market growth is anticipated to boost owing to its growing uses of the product for cancer. With advancements in epitranscriptomics and epigenomics along with global landscape of RNA and DNA modifications as cancer is growing and it is contributing to gene expression. rRNA pseudouridylation has been associated with tumorigenesis through dysregulation of pseudouridine machinery. It is used in the medical industry to treat cancer by developing pharmacological approaches as a part of cancer therapy. It is also considered as the biomarker for various cancers. Such medical applications of the product are anticipated to drive the market growth.     

"Treatment of Other Diseases to Drive Product Demand"

Increasing demand for pseudouridine is growing due to its medical applications in treating other diseases apart from cancer. Mutations associated with mitochondrial and myopathy sideroblastic anemia (MLASA). It is required for neurodevelopmental manifestations. Such diseases require proper pseudouridylation programs. Such growing demand due to its various medical applications to treat other diseases is anticipated to fuel the demand in the pseudouridine market.   

RESTRAINING FACTORS

"Harmful Effects of the Product to Hamper Market Growth"

There are a number of factors that can push the growth of the pseudouridine market. Restraining factors such as excess catabolism is expected to restrain the market growth. Excess catabolism can lead to strong accumulation and increased content of the product. It can delay germination and growth inhibition. This factor is anticipated to restrict and limit the market growth.

Pseudouridine Market REGIONAL INSIGHTS

• 
• Request a Free sample to learn more about this report

"North America to Lead Market Due to Growing R&D Activities"

North America holds the largest part of the global pseudouridine market share due to various R&D activities by market players. Increasing health problems amongst the population in the region is expected to drive the market growth. Growing medical cases of cancer and other diseases is anticipated to facilitate the product demand for the region. Increasing R&D activities regarding products to develop various vaccines and for scientific research is also expected to increase the market share. Increasing number of clinical trials for different types of vaccines is anticipated to drive the market and growth.     

KEY INDUSTRY PLAYERS

"Market Players to Boost Market Growth"

The report delivers information about the list of market players and their operations in the industry. The information is collected and reported with proper research, technological developments, acquisitions, mergers, expanding production lines, and partnerships. Other aspects examined for this market include companies producing and introducing new products, regions they conduct their operations in, automation, technology adoption, generating the most revenue, and making a difference with their products.

List of Market Players Profiled

• BOC Sciences (U.S.)
• YAMASA (Japan)
• TriLink BioTechnologies (Maravai LifeSciences) (U.S.)
• Thermo Scientific Chemicals (U.S.)
• Biosynth Carbosynth (U.K.­)
• Wuhan Glycogen (China)
• Ulcho Biochemical Ltd (FCAD Group)
• Shanghai Hongene Biotech (China)
• Wuhan Finetech (China)
• MP Biomedicals (U.S.)
• Toronto Research Chemical (Canada)

REPORT COVERAGE

This research profiles a report with extensive studies that take into description of the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics changes.